Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 6/20 | 0.77 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.77 |
| ▸ | LMNA | P02545 | 1/20 | 0.77 |
| ▸ | PGR | P06401 | 1/20 | 0.77 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.77 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.77 |
| ▸ | MAPT | P10636 | 1/20 | 0.77 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.77 |
| ▸ | HPGD | P15428 | 1/20 | 0.77 |
| ▸ | CBR1 | P16152 | 1/20 | 0.77 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.77 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.77 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.77 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12286177 | 0.93 | TTR (0.77) | TTRNR1I2LMNAPGRHSP90AA1 | |
| SCHEMBL19294249 | 0.91 | TTR (0.67) | TTRNR1I2LMNAPGRHSP90AA1 | |
| SCHEMBL19843836 | 0.91 | TTR (0.61) | TTRNR1I2LMNAPGRHSP90AA1 | |
| Triclosan SCHEMBL28283932 | 0.87 | TTR (0.92) | TTRNR1I2LMNAPGRHSP90AA1 | |
| Triclosan SCHEMBL526378 | 0.87 | TTR (1.00) | TTRNR1I2LMNAPGRHSP90AA1 | |
| Triclosan SCHEMBL29356111 | 0.87 | TTR (1.00) | TTRNR1I2LMNAPGRHSP90AA1 | |
| Triclosan SCHEMBL29354475 | 0.87 | TTR (1.00) | TTRNR1I2LMNAPGRHSP90AA1 | |
| Triclosan SCHEMBL3269 | 0.87 | TTR (1.00) | TTRNR1I2LMNAPGRHSP90AA1 | |
| Triclosan SCHEMBL29367506 | 0.87 | TTR (1.00) | TTRNR1I2LMNAPGRHSP90AA1 | |
| Triclosan SCHEMBL8975439 | 0.85 | TTR (0.96) | TTRNR1I2LMNAPGRHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11666050-B2 | Enhancing the antimicrobial activity of biocides with polymers | BASF SE (DE) | 2023-06-06 | — | — | US | disclosed |
| US-11647746-B2 | Enhancing the antimicrobial activity of biocides with polymers | BASF SE (DE) | 2023-05-16 | — | — | US | disclosed |
| US-9757407-B2 | Treatment of viral infections by modulation of host cell metabolic pathways | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2017-09-12 | — | — | US | disclosed |
| US-20160346309-A1 | TREATMENT OF VIRAL INFECTIONS BY MODULATION OF HOST CELL METABOLIC PATHWAYS | UNIV PRINCETON (US) | 2016-12-01 | — | — | US | disclosed |
| US-20150182436-A1 | DEODORANT COMPOSITIONS HAVING ANTIBACTERIAL AND ODOR BLOCKING PROPERTIES AND METHODS FOR USING THE SAME | THE DIAL CORPORATION | 2015-07-02 | — | — | US | disclosed |
| US-20150139949-A1 | ANTI-VIRAL COMBINATION THERAPY | KOYUNCU EMRE (US) | 2015-05-21 | — | — | US | disclosed |
| US-9029413-B2 | Treatment of viral infections by modulation of host cell metabolic pathways | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2015-05-12 | — | — | US | disclosed |
| US-20140369953-A1 | Enhancing the Antimicrobial Activity of Biocides with Polymers | BASF SE (DE) | 2014-12-18 | — | — | US | disclosed |
| US-20130065850-A1 | TREATMENT OF VIRAL INFECTIONS BY MODULATION OF HOST CELL METABOLIC PATHWAYS | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2013-03-14 | — | — | US | disclosed |
| US-20120276219-A1 | COMPOSITIONS HAVING A HIGH ANTIVIRAL AND ANTIBACTERIAL EFFICACY | THE DIAL CORPORATION (US) | 2012-11-01 | — | — | US | disclosed |
| US-20120141600-A1 | Compositions Having a High Antiviral and Antibacterial Efficacy | THE DIAL CORPORATION (US) | 2012-06-07 | — | — | US | disclosed |
| US-7795196-B2 | Hand-washing method utilizing antimicrobial liquid hand soap compositions with tactile signal | GEORGIA-PACIFIC CONSUMER PRODUCTS LP (US) | 2010-09-14 | — | — | US | disclosed |
| US-20090175761-A1 | Hand-washing method utilizing antimicrobial liquid hand soap compositions with tactile signal | GPCP IP HOLDINGS LLC | 2009-07-09 | — | — | US | disclosed |
| US-7521404-B2 | Antimicrobial liquid hand soap composition with tactile signal comprising a phospholipid surfactant | GEORGIA-PACIFIC CONSUMER PRODUCTS LP (US) | 2009-04-21 | — | — | US | disclosed |
| WO-2007142967-A2 | ALCOHOL-CONTAINING ANTIMICROBIAL COMPOSITIONS HAVING IMPROVED EFFICACY | THE DIAL CORPORATION (US) | 2007-12-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11647746-B2 | Enhancing the antimicrobial activity of biocides with polymers | CAT, AOC1, DDT | TTR 4735/4885NR1I2 4422/4885LMNA 4556/4885 |
| US-20120276219-A1 | COMPOSITIONS HAVING A HIGH ANTIVIRAL AND ANTIBACTERIAL EFFICACY | ZC3HAV1, ZC3HAV1L, ZFR | TTR 2062/4885NR1I2 3136/4885LMNA 4166/4885 |
| US-20160346309-A1 | TREATMENT OF VIRAL INFECTIONS BY MODULATION OF HOST CELL METABOLIC PATHWAYS | GOT2, MAVS, ME3 | TTR 4184/4885NR1I2 2008/4885LMNA 4191/4885 |
| US-20140369953-A1 | Enhancing the Antimicrobial Activity of Biocides with Polymers | CAT, AOC1, DDT | TTR 4735/4885NR1I2 4422/4885LMNA 4556/4885 |
| US-20150182436-A1 | DEODORANT COMPOSITIONS HAVING ANTIBACTERIAL AND ODOR BLOCKING PROPERTIES AND METHODS FOR USING THE SAME | LPO, TYR, DDO | TTR 1766/4885NR1I2 3702/4885LMNA 4617/4885 |
| US-11666050-B2 | Enhancing the antimicrobial activity of biocides with polymers | CAT, AOC1, DDT | TTR 4735/4885NR1I2 4422/4885LMNA 4556/4885 |
| US-20130065850-A1 | TREATMENT OF VIRAL INFECTIONS BY MODULATION OF HOST CELL METABOLIC PATHWAYS | GOT2, MAVS, ME3 | TTR 4184/4885NR1I2 2008/4885LMNA 4191/4885 |
| US-20120141600-A1 | Compositions Having a High Antiviral and Antibacterial Efficacy | ZC3HAV1, ZC3HAV1L, ZFR | TTR 2062/4885NR1I2 3136/4885LMNA 4166/4885 |
| US-20150139949-A1 | ANTI-VIRAL COMBINATION THERAPY | HAVCR2, MAVS, ZC3HAV1 | TTR 4465/4885NR1I2 2064/4885LMNA 4540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.